Search
01/03/2024
Persistentsciatic artery, an uncommon cause of femoropopliteal occlusion
Casademont, EB, Molina, JM. Persistentsciatic artery, an uncommon cause of femoropopliteal occlusion. Angiologia. 2024; 76(2)DOI:10.20960/angiologia.00496. PMID:. IF:(Q/D).
01/03/2024
A phase II study of retifanlimab, a humanized anti-PD-1 monoclonal antibody, in patients with solid tumors (POD1UM-203)
Di Giacomo, AM, Schenker, M, Medioni, J, Mandziuk, S, Majem, M, Gravis, G, Cornfeld, M, Ranganathan, S, Lou, S, Csoszi, T. A phase II study of retifanlimab, a humanized anti-PD-1 monoclonal antibody, in patients with solid tumors (POD1UM-203). ESMO Open. 2024; 9(3)DOI:10.1016/j.esmoop.2024.102387. PMID:38401247. IF:8.300(Q1/2D).
01/03/2024
Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms (vol 13, 1223282, 2023)
Grünwald, V, Powles, T, Eto, M, Kopyltsov, E, Rha, SY, Porta, C, Motzer, R, Hutson, TE, Méndez-Vidal, MJ, Hong, SH, Winquist, E, Goh, JC, Maroto, P, Buchler, T, Takagi, T, Burgents, JE, Perini, R, He, CX, Okpara, CE, McKenzie, J, Choueiri, TK. Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms (vol 13, 1223282, 2023). Frontiers in Oncology. 2024; 13DOI:10.3389/fonc.2023.1343027. PMID:38495081. IF:3.300(Q2/4D).
01/03/2024
What About Variant Histologies in Bladder Cancer?
Day, E, Gavira, J, Tapia, JC, Anguera, G, Maroto, P. What About Variant Histologies in Bladder Cancer?. European Urology Focus. 2024; 10(2)DOI:10.1016/j.euf.2024.05.015. PMID:38849276. IF:5.600(Q1/1D).
01/03/2024
Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative Breast Cancer Treated with Neoadjuvant Therapy
Arqueros, C, Gallardo, A, Vidal, S, Osuna-Gómez, R, Tibau, A, Bell, OL, Cajal, T, Lerma, E, Lobato-Delgado, B, Salazar, J, Barnadas, A. Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative Breast Cancer Treated with Neoadjuvant Therapy. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(5)DOI:10.3390/ijms25052627. PMID:38473874. IF:4.900(Q1/3D).
01/03/2024
A Clinicopathologic and Immunohistochemical Analysis of 46 Uterine Mesenchymal Tumors Including Conventional Adenosarcomas, Atypical Uterine Polyps and Other Related Sarcomas
Angelo, ED, Espinosa, I, Wang, AH, Kingsley, L, Nasr, S, Zdravkovic, S, Howitt, B, Prat, J. A Clinicopathologic and Immunohistochemical Analysis of 46 Uterine Mesenchymal Tumors Including Conventional Adenosarcomas, Atypical Uterine Polyps and Other Related Sarcomas. LABORATORY INVESTIGATION. 2024; 104(3)DOI:. PMID:. IF:4.200(Q1/1D).
01/03/2024
Loss of Expression of ARID1a and PBRM1 Proteins Is Associated with Poor Prognosis in Mullerian Adenosarcomas
Espinosa, I, D'Angelo, E, Gallardo, A, Lee, CH, Koebel, M, Prat, J. Loss of Expression of ARID1a and PBRM1 Proteins Is Associated with Poor Prognosis in Mullerian Adenosarcomas. LABORATORY INVESTIGATION. 2024; 104(3)DOI:. PMID:. IF:4.200(Q1/1D).
01/03/2024
Tumor Microenvironment in Dedifferentiated and Undifferentiated Endometrial Carcinomas: The Emerging Role of Spatial Cancer-Immunophenotypes and HLA Class I Expression
De Leo, A, Ceccarelli, C, Grillini, M, de Biase, D, Tallini, G, Espinosa, I, Koebel, M, Lee, CH. Tumor Microenvironment in Dedifferentiated and Undifferentiated Endometrial Carcinomas: The Emerging Role of Spatial Cancer-Immunophenotypes and HLA Class I Expression. LABORATORY INVESTIGATION. 2024; 104(3)DOI:. PMID:. IF:4.200(Q1/1D).
01/03/2024
Prognostic capacity of PIV (pan-immune-inflammation value) in patients with head and neck squamous cell carcinoma
Sansa, A, Valero, C, Pujol, A, Sauter, B, Gayà, J, Quer, M, León, X. Prognostic capacity of PIV (pan-immune-inflammation value) in patients with head and neck squamous cell carcinoma. Acta Otorrinolaringologica Espanola. 2024; 75(2)DOI:10.1016/j.otorri.2023.07.005. PMID:38220048. IF:(Q/D).
01/03/2024
Surgical treatment of 186 sinonasal inverted papillomas and analysis of the immunohistochemical and molecular features associated with recurrences*
Gras-Cabrerizo, JR, Martel-Martin, M, Casasayas-Plass, M, Kolanczak, K, Lopez-Vilaró, L, Szafranska, J, Massegur-Solench, H, León-Vintró, X. Surgical treatment of 186 sinonasal inverted papillomas and analysis of the immunohistochemical and molecular features associated with recurrences*. AMERICAN JOURNAL OF OTOLARYNGOLOGY. 2024; 45(2)DOI:10.1016/j.amjoto.2023.104129. PMID:38070378. IF:1.700(Q2/4D).
01/03/2024
Diagnosis and clinical management of thrombotic thrombocytopenic purpura (TTP): a consensus statement from the TTP Catalan group
Muñoz NG, Ortega S, Solanich X, Cid J, Díaz M, Moreno AB, Ancochea Á, Santos M, Hernández I, Sanchez JM, Luaña A, García J, Escoda L, Medina L, Ferrer GJ, López J, Céspedes R, Díaz JA, Pons V, Valcárcel D, Grifols JR. Diagnosis and clinical management of thrombotic thrombocytopenic purpura (TTP): a consensus statement from the TTP Catalan group. Blood Transfusion. 2024; 22(2)DOI:10.2450/BloodTransfus.522. PMID:37677097. IF:2.300(Q2/5D).
01/03/2024
Prodromal symptoms and the duration of untreated psychosis in first episode of psychosis patients: what differences are there between early vs. adult onset and between schizophrenia vs. bipolar disorder?
Baeza, I, de la Serna, E, Mezquida, G, Cuesta, MJ, Vieta, E, Amoretti, S, Lobo, A, González-Pinto, A, Díaz-Caneja, CM, Corripio, I, Valli, I, Puig, O, Mané, A, Bioque, M, Ayora, M, Bernardo, M, Castro-Fornieles, J. Prodromal symptoms and the duration of untreated psychosis in first episode of psychosis patients: what differences are there between early vs. adult onset and between schizophrenia vs. bipolar disorder?. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2024; 33(3)DOI:10.1007/s00787-023-02196-7. PMID:37027026. IF:4.900(Q1/1D).
01/03/2024
Randomized controlled trials in nursing conducted by Latin American research teams: A scoping review
Medina-Aedo, M, Segura-Carrillo, C, Torralba-Martinez, E, Buitrago-García, D, Solà, I, Pardo-Hernandez, H, Bonfill, X. Randomized controlled trials in nursing conducted by Latin American research teams: A scoping review. JOURNAL OF NURSING SCHOLARSHIP. 2024; 56(2)DOI:10.1111/jnu.12943. PMID:37965861. IF:2.900(Q1/2D).
01/03/2024
Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission
Stockbauer, A, Beyer, L, Huber, M, Kreuzer, A, Palleis, C, Katzdobler, S, Rauchmann, BS, Morbelli, S, Chincarini, A, Bruffaerts, R, Vandenberghe, R, Kramberger, MG, Trost, M, Garibotto, V, Nicastro, N, Lathuilière, A, Lemstra, AW, van Berckel, BNM, Pilotto, A, Padovani, A, Ochoa-Figueroa, MA, Davidsson, A, Camacho, V, Peira, E, Bauckneht, M, Pardini, M, Sambuceti, G, Aarsland, D, Nobili, F, Gross, M, Vöglein, J, Perneczky, R, Pogarell, O, Buerger, K, Franzmeier, N, Danek, A, Levin, J, Höglinger, GU, Bartenstein, P, Cumming, P, Rominger, A, Brendel, M. Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2024; DOI:10.1007/s00259-023-06493-w. PMID:37971501. IF:7.600(Q1/1D).
01/03/2024
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study
Torres, T, Chiricozzi, A, Puig, L, Lé, AM, Marzano, AV, Dapavo, P, Dauden, E, Carrascosa, JM, Lazaridou, E, Duarte, G, Carvalho, AVE, Romiti, R, Rompoti, N, Teixeira, L, Abreu, M, Ippoliti, E, Maronese, CA, Llamas-Velasco, M, Vilarrasa, E, del Alcázar, E, Daponte, AI, Papoutsaki, M, Carugno, A, Bellinato, F, Gisondi, P. Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. 2024; 25(2)DOI:10.1007/s40257-024-00845-4. PMID:38265746. IF:8.800(Q1/1D).
01/03/2024
Down Syndrome Biobank Consortium: A perspective
Aldecoa, I, Barroeta, I, Carroll, SL, Fortea, J, Gilmore, A, Ginsberg, SD, Guzman, SJ, Hamlett, ED, Head, E, Perez, SE, Potter, H, Molina-Porcel, L, Raha-Chowdhury, R, Wisniewski, T, Yong, WH, Zaman, S, Ghosh, S, Mufson, EJ, Granholm, AC. Down Syndrome Biobank Consortium: A perspective. ALZHEIMERS & DEMENTIA. 2024; 20(3)DOI:10.1002/alz.13692. PMID:38270275. IF:11.100(Q1/1D).
01/03/2024
Clinical and functional characteristics, possible causes, and impact of chronic cough in patients with cerebellar ataxia, neuropathy, and bilateral vestibular areflexia syndrome (CANVAS)
Palones, E, Curto, E, Plaza, V, Gonzalez-Quereda, L, Segarra-Casas, A, Querol, L, Bertoletti, F, Rodriguez, MJ, Gallano, P, Crespo-Lessmann, A. Clinical and functional characteristics, possible causes, and impact of chronic cough in patients with cerebellar ataxia, neuropathy, and bilateral vestibular areflexia syndrome (CANVAS). JOURNAL OF NEUROLOGY. 2024; 271(3)DOI:10.1007/s00415-023-12001-9. PMID:37917234. IF:4.600(Q1/2D).
01/03/2024
Clinical and outcome comparison of genetically positive vs. negative patients in a large cohort of suspected familial hypocalciuric hypercalcemia
Asla, Q, Sarda, H, Segui, N, de Pinillos, GM, Mazarico-Altisent, I, Capel, I, Rives, J, Suarez, J, avila-Rubio, V, Torres, MM, Saigi, I, Palacios, N, Urgell, E, Webb, SM, Fernandez, M, Oriola, J, Mora, M, Tondo, M, Aulinas, A. Clinical and outcome comparison of genetically positive vs. negative patients in a large cohort of suspected familial hypocalciuric hypercalcemia. ENDOCRINE. 2024; 83(3)DOI:10.1007/s12020-023-03560-y. PMID:38214877. IF:2.900(Q2/5D).
01/03/2024
Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for = 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial
Puig L, Costanzo A, de Jong EMGJ, Torres T, Warren RB, Wapenaar R, Wegner S, Gorecki P, Gramiccia T, Jazra M, Buyze J, Conrad C. Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for = 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. 2024; 25(2)DOI:10.1007/s40257-023-00816-1. PMID:37804472. IF:8.800(Q1/1D).
01/03/2024
Contextual factors for the successful implementation of self-management interventions for chronic diseases: A qualitative review of reviews
Noordman J., Meurs M., Poortvliet R., Rusman T., Orrego-Villagran C., Ballester M., Ninov L., de Guzmán E.N., Alonso-Coello P., Groene O., Suñol R., Heijmans M., Wagner C.. Contextual factors for the successful implementation of self-management interventions for chronic diseases: A qualitative review of reviews. Chronic Illness. 2024; 20(1)DOI:10.1177/17423953231153337. PMID:36744382. IF:1.800(Q2/4D).